The discovery of the NGF pathway resolved the paradox that, in the brain of AD sufferers, BFCNs degenerate while the levels of NGF transcripts remain unchanged [92,93,94] and the protein levels of the NGF precursor, proNGF, are greatly elevated [94,95,96,97,98,99,100]. Here, NGF is linked to Alzheimer disease.